These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


309 related items for PubMed ID: 16848106

  • 1. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Athanassiadou F, Tragiannidis A, Rousso I, Katsos G, Sidi V, Papageorgiou T, Papastergiou C, Tsituridis I, Koliouskas D.
    Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
    Athanassiadou F, Tragiannidis A, Rousso I, Katsos G, Sidi V, Koliouskas D, Papastergiou C, Tsituridis I.
    Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
    [Abstract] [Full Text] [Related]

  • 3. Bone mineralization defects after treatment of acute lymphoblastic leukemia ın children.
    Guren Dolu M, Canbolat Ayhan A, Erguven M, Timur C, Yoruk A, Ozdemir S.
    Minerva Pediatr; 2015 Oct; 67(5):419-25. PubMed ID: 26377781
    [Abstract] [Full Text] [Related]

  • 4. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K, Konstantynowicz J, Krawczuk-Rybak M.
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [Abstract] [Full Text] [Related]

  • 5. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Tillmann V, Darlington AS, Eiser C, Bishop NJ, Davies HA.
    J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
    [Abstract] [Full Text] [Related]

  • 6. Reduced bone density at completion of chemotherapy for a malignancy.
    Arikoski P, Komulainen J, Riikonen P, Jurvelin JS, Voutilainen R, Kröger H.
    Arch Dis Child; 1999 Feb; 80(2):143-8. PubMed ID: 10325729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
    Vitanza NA, Hogan LE, Zhang G, Parker RI.
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):356-61. PubMed ID: 25222061
    [Abstract] [Full Text] [Related]

  • 9. [Leptin, body composition and bone mineralization in children after treatment for Wilms tumor].
    Muszyńska-Rosłan K, Krawczuk-Rybak M, Konstantynowicz J, Wołczyński S, Siedlecka E.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Jul; 10(1):53-8. PubMed ID: 15355740
    [Abstract] [Full Text] [Related]

  • 10. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
    Gunes AM, Can E, Saglam H, Ilçöl YO, Baytan B.
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
    [Abstract] [Full Text] [Related]

  • 11. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Jain S, Jain S, Kapoor G, Virmani A, Bajpai R.
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
    [Abstract] [Full Text] [Related]

  • 12. Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.
    Lequin MH, van der Shuis IM, Van Rijn RR, Hop WC, van ven Huevel-Eibrink MM, MuinckKeizer-Schrama SM, van Kuijk C.
    J Clin Densitom; 2002 Apr; 5(2):167-73. PubMed ID: 12110760
    [Abstract] [Full Text] [Related]

  • 13. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
    Brennan BM, Rahim A, Adams JA, Eden OB, Shalet SM.
    Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
    [Abstract] [Full Text] [Related]

  • 14. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
    Muszyńska-Rosłan K, Konstantynowicz J, Krawczuk-Rybak M, Łuczyński W, Kaczmarski M, Wołczynski S, Piotrowska-Jastrzebska J.
    Med Wieku Rozwoj; 2004 Apr; 8(4 Pt 2):1041-54. PubMed ID: 15951599
    [Abstract] [Full Text] [Related]

  • 15. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, Sebag G, Vilmer E, Léger J.
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A, Yetgin S, Cetin M, Tuncer M, Gumruk F, Gurgey A, Yordam N.
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [Abstract] [Full Text] [Related]

  • 17. Relative osteopenia after treatment for acute lymphoblastic leukemia.
    Warner JT, Evans WD, Webb DK, Bell W, Gregory JW.
    Pediatr Res; 1999 Apr; 45(4 Pt 1):544-51. PubMed ID: 10203147
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
    Thomas IH, Donohue JE, Ness KK, Dengel DR, Baker KS, Gurney JG.
    Cancer; 2008 Dec 01; 113(11):3248-56. PubMed ID: 18932250
    [Abstract] [Full Text] [Related]

  • 19. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
    Bloomhardt HM, Sint K, Ross WL, Rotatori J, Ness K, Robinson C, Carpenter TO, Chow EJ, Kadan-Lottick NS.
    Cancer; 2020 Jan 01; 126(1):202-210. PubMed ID: 31536650
    [Abstract] [Full Text] [Related]

  • 20. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
    Muszynska-Roslan K, Panasiuk A, Latoch E, Krawczuk-Rybak M, Konstantynowicz J.
    J Clin Densitom; 2012 Jan 01; 15(1):108-15. PubMed ID: 21880524
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.